Publications by authors named "Michael Allgauer"

Claim this Profile
I
Impact of Combined Additional Resections on the Surgical Outcomes of Robot-Assisted Resection of Thymic Epithelial Tumors.
Benedikt Niedermaier, Nabil Khan, Florian Eichhorn, Maria Zehentmeier, Heidrun Grosch

J Surg Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advancing Lung Cancer Staging: Integrating IASLC Recommendations and Bioinformatics to Delineate Tumor Origins.
Michael Allgäuer, Klaus Kluck, Petros Christopoulos, Markus Ball, Anna-Lena Volckmar

J Thorac Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of a novel RSPO1-NUMT insertion in a LUAD patient cohort and the challenges and insights into NUMT detection highlighting the importance of reference genomes and population databases.
Ilona Tietzova, Dana Sochorova, Petr Triska, Rebecca C Rancourt, Marek Omelka

Transl Lung Cancer Res· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic impact of lepidic growth in intermediate and high-grade lung adenocarcinoma.
Benedikt Niedermaier, Erik Rolf, Michael Allgäuer, Laura V Klotz, Marc A Schneider

Lung Cancer· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant anti-programmed death-1 immunotherapy by pembrolizumab in resectable non-small cell lung cancer: results of the NEOMUN trial.
Martin E Eichhorn, Benedikt Niedermaier, Pornpimol Charoentong, Laura V Klotz, Philip Baum

J Immunother Cancer· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differentiating Main-Duct IPMN from Chronic Pancreatitis Using Next-Generation Sequencing of Main Pancreatic Duct Fluid: A Pilot Study.
Daniel Schmitz, Stefan Prax, Martin Kliment, Felix Gocke, Daniel Kazdal

Diagnostics (Basel)· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic landscape and molecularly informed therapy in thymic carcinoma and other advanced thymic epithelial tumors.
Lino Möhrmann, Lysann Rostock, Maximilian Werner, Małgorzata Oleś, Jonas S Arnold

Med· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Robotic-assisted versus open resection of pulmonary sequestration: a retrospective cohort study. RATS surgery for pulmonary sequestration.
Henrike Deissner, Alessio Campisi, Raffaella Griffo, Benedikt Niedermaier, Thomas Muley

Gen Thorac Cardiovasc Surg· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Wnt/β-catenin activation by mutually exclusive FBXW11 and CTNNB1 hotspot mutations drives salivary basal cell adenoma.
Kim Wong, Justin A Bishop, Ilan Weinreb, Marialetizia Motta, Martin Del Castillo Velasco-Herrera

Nat Commun· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sex-specific aspects in a population of patients undergoing evaluation for interstitial lung disease with transbronchial cryobiopsy.
Janna Reinhard, Markus Polke, Katharina Buschulte, Monika Eichinger, Claus Peter Heußel

Sci Rep· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Implementation of a High-Throughput Automated Comprehensive Genomic Profiling Test: TruSight Oncology 500 HT.
Markus Ball, Eva Romanovsky, Fabian Schnecko, Martina Kirchner, Olaf Neumann

J Mol Diagn· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epitranscriptomic rRNA fingerprinting reveals tissue-of-origin and tumor-specific signatures.
Ivan Milenkovic, Sonia Cruciani, Laia Llovera, Morghan C Lucas, Rebeca Medina

Mol Cell· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intratumor Heterogeneity Predicts Prognosis in Lepidic Predominant Lung Adenocarcinoma.
Benedikt Niedermaier, Michael Allgäuer, Thomas Muley, Marc A Schneider, Martin E Eichhorn

Thorac Cancer· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Small cell transformation in EGFR-mutated non-small cell lung cancer: DLL3 expression and efficacy of immune checkpoint inhibitors or tyrosine kinase inhibitors combined with chemotherapy.
Felix Carl Saalfeld, Johanna Möller, Petros Christopoulos, Carina Wenzel, Anna Rasokat

Eur J Cancer· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The pregnancy-associated protein glycodelin as a potential sex-specific target for resistance to immunotherapy in non-small cell lung cancer.
Sarah Richtmann, Sebastian Marwitz, Thomas Muley, Hannu Koistinen, Petros Christopoulos

Transl Res· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumour mutational burden: clinical utility, challenges and emerging improvements.
Jan Budczies, Daniel Kazdal, Michael Menzel, Susanne Beck, Klaus Kluck

Nat Rev Clin Oncol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of T Cell Ratios on Survival in Pleural Mesothelioma: Insights from Tumor Microenvironment Analysis.
Laura V Klotz, Andreas Weigert, Florian Eichhorn, Michael Allgäuer, Thomas Muley

Cancers (Basel)· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multidisciplinary approach to mucormycosis.
Michael S Abers, Phuong Vo, Michael Allgäuer, Maura Manion, John A Butman

J Infect· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peri- and postoperative morbidity and mortality in older patients with non-small cell lung cancer: a matched-pair study.
Seyer Safi, Maximilian Robert Gysan, Dorothea Weber, Rouven Behnisch, Thomas Muley

World J Surg Oncol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to "First-line immunotherapy for lung cancer with MET exon 14 skipping and the relevance of TP53 mutations" [Eur J Cancer 199 (2024) 113556].
Miriam Blasi, Jonas Kuon, Heike Lüders, Daniel Misch, Diego Kauffmann-Guerrero

Eur J Cancer· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Leveraging Off-Target Reads in Panel Sequencing for Homologous Recombination Repair Deficiency Screening in Tumor.
Markus Ball, Iordanis Ourailidis, Klaus Kluck, Michael Menzel, Martina Kirchner

J Mol Diagn· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-line immunotherapy for lung cancer with MET exon 14 skipping and the relevance of TP53 mutations.
Miriam Blasi, Jonas Kuon, Heike Lüders, Daniel Misch, Diego Kauffmann-Guerrero

Eur J Cancer· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic heterogeneity at baseline is associated with T790M resistance mutations in EGFR-mutated lung cancer treated with the first-/second-generation tyrosine kinase inhibitors.
Michael Menzel, Martina Kirchner, Klaus Kluck, Markus Ball, Susanne Beck

J Pathol Clin Res· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of rare fusions in NSCLC: Genomic architecture and clinical implications.
Huriye Seker-Cin, Timothy Kwang Yong Tay, Daniel Kazdal, Klaus Kluck, Markus Ball

Lung Cancer· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multicentric pilot study to standardize clinical whole exome sequencing (WES) for cancer patients.
Michael Menzel, Stephan Ossowski, Sebastian Kral, Patrick Metzger, Peter Horak

NPJ Precis Oncol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis